Glenmede Trust CO Na Cytokinetics Inc Transaction History

Glenmede Trust CO Na

$20.6 Billion
Q3 2024

A detailed history of Glenmede Trust CO Na transactions in Cytokinetics Inc stock. As of the latest transaction made, Glenmede Trust CO Na holds 6,261 shares of CYTK stock, worth $303,846. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,261

Previous 9,022 30.6%

Holding current value

$303,846

Previous $488,000 32.38%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$51.22 - $60.16 $141,418 - $166,101	-2,761 Reduced 30.6%	6,261 $330,000
Q2 2024 Aug 14, 2024	BUY	$47.86 - $75.05 $47,572 - $74,599	994 Added 12.38%	9,022 $488,000
Q1 2024 May 15, 2024	BUY	$63.75 - $108.06 $268,387 - $454,932	4,210 Added 110.27%	8,028 $562,000
Q4 2023 Feb 13, 2024	SELL	$26.88 - $83.49 $168,376 - $522,981	-6,264 Reduced 62.13%	3,818 $318,000
Q3 2023 Nov 14, 2023	SELL	$29.46 - $36.61 $63,663 - $79,114	-2,161 Reduced 17.65%	10,082 $297,000
Q1 2023 May 15, 2023	SELL	$33.36 - $45.71 $27,455 - $37,619	-823 Reduced 6.3%	12,243 $430,000
Q4 2022 Feb 14, 2023	SELL	$35.77 - $51.11 $8,835 - $12,624	-247 Reduced 1.86%	13,066 $598,000
Q3 2022 Nov 16, 2022	SELL	$38.54 - $54.52 $216,247 - $305,911	-5,611 Reduced 29.65%	13,313 $645,000
Q2 2022 Aug 15, 2022	BUY	$33.93 - $48.92 $225,770 - $325,513	6,654 Added 54.23%	18,924 $743,000
Q1 2022 May 16, 2022	BUY	$29.74 - $46.0 $4,877 - $7,544	164 Added 1.35%	12,270 $451,000
Q4 2021 Feb 15, 2022	BUY	$34.35 - $46.38 $15,766 - $21,288	459 Added 3.94%	12,106 $551,000
Q3 2021 Nov 15, 2021	BUY	$18.54 - $35.74 $215,935 - $416,263	11,647 New	11,647 $416,000
Q4 2020 Feb 16, 2021	SELL	$15.26 - $28.61 $14,985 - $28,095	-982 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$20.58 - $28.96 $1,502 - $2,114	73 Added 8.03%	982 $21,000
Q2 2020 Aug 14, 2020	BUY	$11.15 - $24.64 $5,285 - $11,679	474 Added 108.97%	909 $21,000
Q4 2019 Feb 12, 2020	SELL	$7.95 - $11.84 $1,375 - $2,048	-173 Reduced 28.45%	435 $4,000
Q3 2019 Nov 14, 2019	BUY	$10.82 - $14.25 $1,157 - $1,524	107 Added 21.36%	608 $6,000
Q2 2019 Aug 13, 2019	BUY	$7.95 - $11.25 $1,709 - $2,418	215 Added 75.17%	501 $5,000
Q1 2019 May 14, 2019	BUY	$5.95 - $10.19 $368 - $631	62 Added 27.68%	286 $2,000
Q4 2018 Feb 14, 2019	BUY	$5.91 - $9.29 $1,323 - $2,080	224 New	224 $1,000

Others Institutions Holding CYTK

# of Institutions

409

Shares Held

125M

Call Options Held

4.6M

Put Options Held

2.43M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.57B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.

Account

Glenmede Trust CO Na Cytokinetics Inc Transaction History